EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, AMED Co's enterprise value is NT$1,906.8 Mil.
AMED Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$157.3 Mil. Therefore, AMED Co's EV-to-EBITDA for today is 12.12.
The historical rank and industry rank for AMED Co's EV-to-EBITDA or its related term are showing as below:
ROCO:7575'
s EV-to-EBITDA Range Over the Past 10 Years
Min: 11.27 Med: 14.7 Max: 18.68
Current: 12.12
During the past 5 years, the highest EV-to-EBITDA of AMED Co was 18.68. The lowest was 11.27. And the median was 14.70.
ROCO:7575's EV-to-EBITDA is ranked better than 62.09% of 488
companies
in the Medical Devices & Instruments industry
Industry Median: 16.145
vs ROCO:7575: 12.12
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
As of today (2024-05-23), AMED Co's stock price is NT$58.60.
AMED Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$3.050. Therefore, AMED Co's PE Ratio for today is 19.21.
The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.
AMED Co EV-to-EBITDA Historical Data
The historical data trend for AMED Co's EV-to-EBITDA can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, AMED Co's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
AMED Co's EV-to-EBITDA Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, AMED Co's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where AMED Co's EV-to-EBITDA falls into.
AMED Co EV-to-EBITDA Calculation
AMED Co's EV-to-EBITDA for today is calculated as:
AMED Co's current Enterprise Value is NT$1,906.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AMED Co's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was NT$157.3 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
AMED Co (ROCO:7575) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
AMED Co's share price for today is NT$58.60.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. AMED Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was NT$3.050.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.
Thank you for viewing the detailed overview of AMED Co's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.
AMED Co Ltd is fully committed to the research and development of UV photopolymerized hydrogels. It is a professional research and development and manufacturing company of wound dressing materials, providing proper wound care solutions, and marketing the product under the brand of Heli Dressing.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
ROCO:7575 has been successfully added to your 